21169 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
VACCINE COMPRISING INACTIVATED CELLS OF HAEMOPHILUS PARASUIS BACTERIA OF SEROTYPE 5
#302Inactivated bacterial cell formulation
#303Inactivating pathogens with oxidizing agents for vaccine production
#304Gene Dro1 Controlling Deep-Rooted Characteristics of Plant and Utilization of Same
#305Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#306Leishmania-based carrier for vaccine delivery
#307Vaccine against cholera and enterotoxigenic (ETEC) diarrhea
#308Immunogenic anti-inflammatory compositions
#309Selectively disrupted whole-cell vaccine
#310Vaccination of sex reversed hybrid tilapia (x ) with an inactivated vaccine
#311bacterin vaccine
#312Vaccines with increased immunogenicity and methods for obtaining them
#313Vaccines comprising heat-sensitive transgenes
#314USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS
#315Antigen compositions and methods of inhibiting bacterial infection and uses of the antigen compositions
#316RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY
#317COMPOSITIONS AND METHODS FOR VACCINATING CATTLE
#318Nanoemulsion vaccines
#319vaccine compositions and methods of using the same
#320Influenza vaccine, composition, and methods of use
#321COMPOSITION
#322Compositions and methods for treatment of microbial infections
#323Method of producing rough strains of bacteria and uses thereof
#324Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria
#325E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
#326Compositions and methods for treating of microbial infections
#327NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#328NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#329Potomac horse fever isolates
#330Outer membrane vesicles and uses thereof
#331E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
#332NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#333Vaccine for protection against bacteria of various serotypes
#334Synergistic combination and method thereof
#335Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#336BORRELLIA BURGDORFERI BACTERIN
#337Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
#338Inactivated chimeric vaccines and related methods of use
#339Non-typeable vaccines and their uses
#340NON-TYPHOIDAL SALMONELLA VACCINES
#341BACTERIAL VACCINE
#342Tissue targeted antigenic activation of the immune response to treat cancers
#343Attenuated bacteria useful in vaccines
#344Methods of immunizing pregnant heifers at three months of gestation
#345ANTI-FUNGAL COMPOSITION
#346Piscirickettsia salmonis antigens and use thereof
#347NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF
#348West Nile Virus vaccine
#349bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel serotype and hybridomas for producing the said antibodies
#350Enzyme treatment of glucans
#351Recombinant Rhinovirus Vectors
#352Treatment and prevention of tuberculosis
#353Vaccine Antigens from Piscirickettsia Salmonis
#354Glucan-based vaccines
#355Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis
#356Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis
#357VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS
#358VACCINE COMPRISING A RIBOSOMAL PROTEIN EXTRACT (RPE) AND OPTIONALLY A TH1-PROMOTING ADJUVANT
#359Tissue targeted antigenic activation of the immune response to treat cancers
#360Preparation of vaccines using photosensitizer and light
#361Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets
#362Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
#363Vaccine Antigens
#364USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX
#365Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#366Therapeutic agent for cancer
#367Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists
#368Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#369strain
#370BOTULINUM NEUROTOXIN VACCINE
#371Inactivated bacterial cell formulation
#372Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens
#373Novel Medicinal Formulation for Inducing an Immune Response in Patients with Chronic and Recurring Infections
#374Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
#375Method of preventing early infections
#376whole-cell vaccine composition
#377Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#378Composition and method for controlling intestinal pathogenic organisms
#379Methods and compositions using for enhancing immunogenicity by prime boost
#380KENNEL COUGH VACCINE
#381Virus-modified bacteria ghosts
#382Inactivated staphylococcal whole-cell vaccine
#383Microfluidized oil-in-water emulsions and vaccine compositions
#384Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#385Compositions and methods for treating microbial infections
#386Yeast-based therapeutic for chronic hepatitis C infection
#387bacterin vaccine
#388Tuberculosis vaccine and method of using same
#389Compositions and methods to elicit immune responses against pathogenic organisms using yeast based vaccines
#390Bacterial ghost (BG) production process using betapropiolactone (BPL) for final inactivation
#391NEW VACCINE FORMULATIONS
#392bacterin vaccine
#393Novel Vaccination Carrier
#394Outer membrane vesicles and uses thereof
#395FRANCISELLA STRAIN FOR LIVE VACCINE
#396Inactivated polio vaccines
#397Vaccine
#398TREATMENT AND PREVENTION OF ALLERGIC AIRWAYS DISEASES
#399Exoenzyme toxin of , and uses therefor
#400Compositions and methods for treatment of microbial infections
#401Vaccine for disease and streptococcal disease in fish
#402Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#403Adjuvant compositions
#404Method of producing rough strains of bacteria and uses thereof
#405RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY
#406DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#407Vaccines for mycoplasma bovis and methods of use
#408Subunit vaccine of in veterinary uses
#409Inactivated Chimeric Vaccines and Related Methods of Use
#410Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
#411Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#412Type III secretion pathway in and uses therefor
#413Vaccines for Mycoplasma bovis and methods of use
#414Combination vaccines with whole cell pertussis antigen
#415Manufacturing Method of Combined Vaccine
#416RECOMBINANT LACTOBACILLUS AND USE OF THE SAME
#417HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS
#418Antigens and vaccines against
#419Vaccine against salmonid rickettsial septicaemia based on cells
#420ACELLULAR IMMUNOGENIC COMPOSITIONS AND ACELLULAR VACCINE COMPOSITIONS AGAINST BACILLUS ANTHRACIS
#421ADJUVANTED VACCINE
#422KENNEL COUGH VACCINE
#423Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria
#424Type III secretion pathway in , and uses therefor
#425Tissue targeted antigenic activation of the immune response to cancers
#426KENNEL COUGH VACCINE
#427Yeast-based therapeutic for chronic hepatitis C infection
#428COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS
#429DETOXIFICATION METHOD
#430IMMUNE SYSTEM STIMULANT AND PROCESS OF MANUFACTURING THE SAME
#431Raccoon poxvirus expressing rabies glycoproteins
#432Vaccine For Periodontal Disease
#433Disease Prevention and Vaccination Prior to Thymic Reactivation
#434COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS
#435Nanoemulsion Vaccines
#436Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous Compound
#437Vaccines for Mycoplasma bovis and methods of use
#438Canine combination vaccines
#439vaccine
#440Sustained release vaccine composition
#441Compositions and methods for treatment of microbial infections
#442Vaccine formulations
#443Nanoemulsion Vaccines
#444Nanoemulsion Vaccines
#445Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
#446CANINE VACCINES
#447Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
#448Method or use of a solubilized glucan product to increase immunostimulation in animals
#449of european origin and vaccines, diagnostic agents and methods of use thereof
#450Oral killed vaccines and method for providing same
#451Yeast-based therapeutic for chronic hepatitis C infection
#452Apparatus for vaccine development using ultrasound technology
#453Salmonella vaccine
#454Vaccines for and methods of use
#455Yeast-based therapeutic for chronic hepatitis C infection
#456Vaccination of young animals against infections
#457BORRELIA BURGDORFERI BACTERIN
#458Kennel cough vaccine
#459Exoenzyme toxin of , and uses therefor
#460Method for Determining Dosage for an Oral Killed Vaccine
#461Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
#462Apparatus and methods for vaccine development using ultrasound technology
#463Immunization Against Clostridium Difficile Disease
#464Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
#465Preparation of Vaccines Using Photosensitizers and Light
#466Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
#467Glucan-based vaccines
#468bacterin vaccine
#469Inactivated host cell delivery of polynucleotides encoding immunogens
#470TISSUE TARGETED ANTIGENIC ACTIVATION OF THE IMMUNE RESPONSE TO CANCERS
#471Vaccines for mycoplasma bovis and methods of use
#472Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#473Methods for testing vaccine candidates against bacterial infection in rodents
#474Preparation of vaccines using a photosensitizer and light
#475Leptospirosis culture process
#476Inactivating pathogens with oxidizing agents for vaccine production
#477Outer membrane vesicles and uses thereof
#478Mycoplasma hyopneumoniae bacterin vaccine
#479Vaccines for protection from Bartonella infection and related methods of use
#480Inactivated chimeric flavivirus
#481Vaccines for immunization against
#482Vaccine for periodontal disease
#483Nanoemulsion vaccines
#484Pharmaceutical composition containing disrupted cell suspension of and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same
#485Inactivated vibrio cholerae vaccine in tablet form
#486Neisserial vaccine compositions comprising a combination of antigens
#487Cells used as carriers for bacteria
#488bacterin vaccine
#489Immunogenic compositions comprising
#490Method of treating human-immunodeficiency virus (HIV) disease infection
#491Canine vaccine for protection against ehrlichiosis
#492Methods for diagnosing and treating chronic tonsillitis
#493Attenuated vaccine useful for immunizations against spp. infections
#494Acellular immunogenic compositions and acellular vaccine compositions against
#495Vaccine for fish cold-water disease
#496Culturing
#497Vaccine composition
#498Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-
#499Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
#500Plasmid maintenance system for antigen delivery
#501Plasmid maintenance system for antigen delivery
#502Mycobacterium smegmatis vaccine
#503Porcine circovirus and Helicobacter combination vaccines and methods of use
#504Plasmid maintenance system for antigen delivery
#505Immunization against clostridium difficile disease
#506Composition for increasing the survival to slaughter rate of piglets
#507Feed for fish and shellfish, additive therefor, and method for producing additive
#508Method or use of a solubilized glucan product to increase immunostimulation in animals
#509Compositions and methods for treatment of microbial infections
#510Microfluidized oil-in-water emulsions and vaccine compositions
#511Glucan-based vaccines
#512vaccine
#513Canine vaccine for protection against ehrlichiosis
#514Immunogenic compositions and methods of use thereof
#515Neisserial vaccine compositions and methods
#516Exoenzyme toxin of , and uses thereof
#517Pharmaceutical composition containing disrupted cell suspension of monilia albicans and euglobulin and method of treating animals infected with canine distemper virus of animals having neurological disorders by using the same
#518Hsp70 from
#519Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
#520Mycobacterial vaccine
#521Vaccines for and methods of use
#522Oral vaccine, method for its preparation and use thereof
#523Canine vaccines against Bordetella bronchiseptica
#524Feed for fish and shellfish, additive therefor, and method for producing additive
#525Vaccine formulations
#526Adjuvants for use in vaccines
#527Type III secretion pathway in , and uses therefor
#528Attenuated bacteria useful in vaccines
#529Vaccines for and methods of use
#530Borrelia burgdorferi bacterin
#531Mycoplasma vaccine, method of making, and application thereof
#532of European origin and vaccines, diagnostic agents and methods of use thereof
#533One dose vaccination with Mycoplasma hyopneumoniae
#534Vaccine for periodontal disease
#535Plasmid maintenance system for antigen delivery
#536Enhanced microbial therapeutic agents
#537Immunotherapy for lyme disease